Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
MarketingRx roundup: Moderna clues in to ‘Jeopardy’; BMS, Gilead build out clinical trial diversity program
3 years ago
Pharma
Marketing
Betting on CD47 as others ditch the target, ALX borrows up to $100M to push sole clinical drug forward
3 years ago
Financing
R&D
Covid-19 continues to befuddle Big Pharma as AbbVie axes PhI of an oral drug
3 years ago
R&D
Coronavirus
Updated: Samsara backs ex-Gilead duo's amalgamation of NASH, liver drug assets from former employer, other biopharmas
3 years ago
Financing
Startups
Updated: Eli Lilly blames Biden's IRA for cancer drug discontinuation as the new pharma playbook takes shape
3 years ago
R&D
FDA+
JP Morgan splashes into the life sciences, tapping Stephen Squinto to run venture team with high-powered advisors
3 years ago
Deals
Bioregnum
Covid-19 spurred a historic vaccine R&D effort. What does it mean for future pandemics?
3 years ago
R&D
Coronavirus
Pfizer declares 'first-ever' PhIII win for RSV vaccine in infants — and it's steering straight to FDA
3 years ago
R&D
A single injection of Unity's anti-aging hypothesis bears fruit in PhII, as pivotal plans shape up
3 years ago
R&D
Drew Armstrong is coming to Endpoints(!) And there are some more surprises to come
3 years ago
Bioregnum
That secretive ARCH biotech with two antibodies from MorphoSys? It’s now got $120M
3 years ago
Financing
Startups
#CPHI22: Endpoints sits down with conference exec as the manufacturing world says ‘Guten Tag’ to CPHI
3 years ago
Manufacturing
#CPHI22: Contract manufacturers will still be navigating global challenges into next year
3 years ago
Outsourcing
Manufacturing
#CPHI22: Annual report shows ‘moderate outlook’ and focus on mRNA
3 years ago
Manufacturing
#CPHI22: A look back at the biggest manufacturing projects in 2022
3 years ago
Manufacturing
#CPHI22: Cell and gene manufacturing expected to see a bump as it moves out of the pandemic
3 years ago
R&D
#CPHI22: Supply chain woes are still bearing down on manufacturers
3 years ago
Manufacturing
Bristol Myers' blockbuster-to-be Reblozyl scores a PhIII win
3 years ago
Pharma
Daiichi Sankyo sets new highs for AstraZeneca-partnered cancer drug Enhertu
3 years ago
Pharma
FDA to kick off CMC readiness pilot program next April
3 years ago
Pharma
FDA+
AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others
3 years ago
Pharma
Law
Under hub-and-spoke biotech, serial founders launch new startup hoping to make gene therapies for the eye
3 years ago
Startups
Cell/Gene Tx
Thermo Fisher wagers on early cancer diagnostics in $2.6B cash deal for multiple myeloma test maker
3 years ago
Deals
Diagnostics
Intrinsic wanted an IPO. Instead, it's a SPAC for the gut-brain microbiome biotech
3 years ago
Financing
Startups
First page
Previous page
430
431
432
433
434
435
436
Next page
Last page